Public Health Interventions on Prescription Redemptions and Secondary Medication Adherence Among Type 2 Diabetes Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2021 Dec 13

PMID 34900834

Citations 2

Authors

Bayu Begashaw Bekele

Biruk Bogale

Samuel Negash

Melkamsew Tesfaye

Dawit Getachew

Fekede Weldekidan

Tewodros Yosef

Affiliations

Soon will be listed here.

Abstract

Background: Despite the inadequate filling of prescriptions among chronic care patients has been a problem, little is known about the intervention effect on it.

Objective: The aim of this systematic review and meta-analysis (SRMA) was to investigate the effectiveness of various public health interventions on primary and secondary medication adherence among T2DM patients.

Methods: Searching was done from the major databases; Cochrane Library, Medline/PubMed, EBSCOhost, and SCOPUS. A hand search was made to find grey works of literature. Articles focused on interventions to enhance primary and secondary medication among type 2 diabetes mellitus patients were included. After screening and checking eligibility, the methodological quality was assessed. Secondary medication adherence was synthesized descriptively due to measurement and definition variations across studies. Finally, a meta-analysis was made using the fixed effects model for primary medication adherence.

Results: 3992 studies were screened for both primary and secondary medication adherences. Among these, 24 studies were included in the analysis for primary (5) and secondary (19) medication adherence. Pooled relative medication redemption difference was RD = 8% (95% CI: 6-11%) among the intervention groups. Age, intervention, provider setting, and IDF region were determinant factors of primary medication adherence. About two-thirds of the studies revealed that interventions were effective in improving secondary medication adherence.

Conclusion: Both primary and secondary medications were enhanced by a variety of public health interventions for patients worldwide. However, there is a scarcity of studies on primary medication adherence globally, and in resource-limited settings for the type of adherences.

Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-021-00878-0.

Citing Articles

Cross-sectional comparison of health care delivery and reimbursement between segregated and nonsegregated communities in Hungary.

Kasabji F, Vincze F, Lakatos K, Palinkas A, Korosi L, Ulicska L Front Public Health. 2024; 12:1152555.

PMID: 38327575 PMC: 10847262. DOI: 10.3389/fpubh.2024.1152555.

Medication Adherence and Contributing Factors Among Type 2 Diabetes Patients at Adama Hospital Medical College in Eastern Ethiopia.

Yosef T, Nureye D, Tekalign E, Assefa E, Shifera N SAGE Open Nurs. 2023; 9:23779608231158975.

PMID: 36844422 PMC: 9944187. DOI: 10.1177/23779608231158975.

References

Schectman J, Bovbjerg V, Voss J . Predictors of medication-refill adherence in an indigent rural population. Med Care. 2002; 40(12):1294-300. DOI: 10.1097/00005650-200212000-00016. View

Hakansson Lindqvist M, Gustafsson M, Gallego G . Exploring physicians, nurses and ward-based pharmacists working relationships in a Swedish inpatient setting: a mixed methods study. Int J Clin Pharm. 2019; 41(3):728-733. PMC: 6554255. DOI: 10.1007/s11096-019-00812-8. View

Whitley H, Fermo J, Ragucci K, Chumney E . Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharm Pract (Granada). 2017; 4(4):183. PMC: 5426583. DOI: 10.4321/s1885-642x2006000400006. View

Lyons I, Barber N, Raynor D, Wei L . The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016; 25(10):759-69. DOI: 10.1136/bmjqs-2015-004670. View

Baggarly S, Kemp R, Wang X, Magoun A . Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Res Social Adm Pharm. 2014; 10(6):e99-e112. DOI: 10.1016/j.sapharm.2014.02.002. View

Lemstra M, Nwankwo C, Bird Y, Moraros J . Primary nonadherence to chronic disease medications: a meta-analysis. Patient Prefer Adherence. 2018; 12:721-731. PMC: 5944464. DOI: 10.2147/PPA.S161151. View

IntHout J, Ioannidis J, Borm G, Goeman J . Small studies are more heterogeneous than large ones: a meta-meta-analysis. J Clin Epidemiol. 2015; 68(8):860-9. DOI: 10.1016/j.jclinepi.2015.03.017. View

Farmer A, Rodgers L, Lonergan M, Shields B, Weedon M, Donnelly L . Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. Diabetes Care. 2015; 39(2):258-263. PMC: 4894467. DOI: 10.2337/dc15-1194. View

Hohmann E, Feldman M, Hunt T, Cote M, Brand J . Research Pearls: How Do We Establish the Level of Evidence?. Arthroscopy. 2018; 34(12):3271-3277. DOI: 10.1016/j.arthro.2018.10.002. View

10.

Nouamou I, Mourid M, Ragbaoui Y, Habbal R . [Medication adherence among elderly patients with coronary artery disease: our experience in Morocco]. Pan Afr Med J. 2019; 32:8. PMC: 6492307. DOI: 10.11604/pamj.2019.32.8.12415. View

11.

McGinnis B, Kauffman Y, Olson K, Witt D, Raebel M . Interventions aimed at improving performance on medication adherence metrics. Int J Clin Pharm. 2013; 36(1):20-5. DOI: 10.1007/s11096-013-9872-y. View

12.

Gast A, Mathes T . Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019; 8(1):112. PMC: 6511120. DOI: 10.1186/s13643-019-1014-8. View

13.

Lunghi C, Zongo A, Moisan J, Gregoire J, Guenette L . Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression. J Diabetes Complications. 2017; 31(7):1200-1206. DOI: 10.1016/j.jdiacomp.2017.02.016. View

14.

Amir-Behghadami M, Janati A . Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020; 37(6):387. DOI: 10.1136/emermed-2020-209567. View

15.

Cahir C . Primary nonadherence: the forgotten component of medication adherence?. Pol Arch Intern Med. 2020; 130(1):1-3. DOI: 10.20452/pamw.15164. View

16.

Harris J, Haltbakk J, Dunning T, Austrheim G, Kirkevold M, Johnson M . How patient and community involvement in diabetes research influences health outcomes: A realist review. Health Expect. 2019; 22(5):907-920. PMC: 6803418. DOI: 10.1111/hex.12935. View

17.

Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E . Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 2012; 7(2):111-8. DOI: 10.1016/j.pcd.2012.11.001. View

18.

Lo-Ciganic W, Donohue J, Jones B, Perera S, Thorpe J, Thorpe C . Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. J Gen Intern Med. 2016; 31(9):1052-60. PMC: 4978686. DOI: 10.1007/s11606-016-3747-6. View

19.

Katz D, Karlsen M, Chung M, Shams-White M, Green L, Fielding J . Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review. BMC Med Res Methodol. 2019; 19(1):178. PMC: 6701153. DOI: 10.1186/s12874-019-0811-z. View

20.

Thom D, Willard-Grace R, Hessler D, Devore D, Prado C, Bodenheimer T . The impact of health coaching on medication adherence in patients with poorly controlled diabetes, hypertension, and/or hyperlipidemia: a randomized controlled trial. J Am Board Fam Med. 2015; 28(1):38-45. DOI: 10.3122/jabfm.2015.01.140123. View